In 2018, the global Hospital-Acquired Disease Testing market size was 520 million US$ and it is expected to reach 780 million US$ by the end of 2025, with a CAGR of 5.2% during 2019-2025.
The report Hospital-Acquired Disease Testing Market Market Research highlights key dynamics of Global Hospital-Acquired Disease Testing Market sector. The potential of the Hospital-Acquired Disease Testing Market Market has been investigated along with the key challenges. The current Market scenario and future prospects of the sector has also been studied.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI.
The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged caregivers to devise accurate diagnosis of HAIs for efficient healthcare provision.